News and Reports
-
Corvidia Announces Series B Funding Closure
25 April 2018Download -
Aptinyx Raises $70 Million in Series B Financing to Advance Growing Pipeline through Clinical Studies in Neurologic Disorders
18 December 2017Download -
YmAbs Announces Closing of $30 Million Extension of Private Equity Placement
29 November 2017Download -
Advanced Accelerator Applications Announces $3.9 Billion All Cash Proposed Tender Offer by Novartis
30 October 2017Download -
Y-mAbs Therapeutics, Inc. closes $50 million in a private placement led by HBM Healthcare Investments (HBM) and supported by current shareholder
24 October 2017Download -
Amicus Signs Co-Promotion Contracts with Glaxosmithkline (GSK) for Bosnia and Serbia
17 October 2017Download -
Lupin Acquires Symbiomix Therapeutics LLC
11 October 2017Download -
AnaptysBio Reports Positive Topline Proof-of-Concept Data from Phase 2a Clinical Trial of ANB020 in Atopic Dermatitis
10 October 2017Download -
Harmony Biosciences Acquires US Rights to Pitolisant from Bioprojet; Raises $270 Million in Equity Financing
5 October 2017Download -
ObsEva Completes Patient Recruitment for Phase 3 IVF Trial
6 September 2017Download -
ARMO BioSciences Raises $67 Million in a Series C-1 Financing
29 August 2017Download -
Vascular Dynamics Announces FDA Approval to Initiate CALM 2 Trial for MobiusHD® System for the Treatment of Resistant Hypertension
15 August 2017Download -
Homology Medicines Raises $83.5 Million Series B Round to Advance Gene Therapy Gene Editing
1 August 2017Download -
Advanced Accelerator Applications Completes Resubmission of NDA for Lutetium Lu 177 Dotatate (Lutathera®) to FDA
27 July 2017Download -
HBM & Existing Investors Double Down on 1mg with a $15M Series C Financing
26 July 2017Download -
Complexa Raises $62 Million in Series C Financing to Test CXA-10 in Two Orphan Disease Proof-of-Concept Trials
26 July 2017Download -
Shape Memory Medical Raises Series B, Led by HBM Healthcare Investments Ltd.
25 July 2017Download -
Advanced Accelerator Applications Announces Positive CHMP Opinion Recommending Approval of Lutetium 177Lu Oxodotreotide (Lutathera®) for Gastroenteropancreatic Neuroendocrine (GEP-NET) Tumors
21 July 2017Download -
Amphora Medical Closes $35.5 Million Series B Financing
20 July 2017Download -
Paratek Announces Phase 3 Study of Oral-Only Dosing of Omadacycline Met All Primary and Secondary FDA and Endpoints in Acute Bacterial Skin Infections
17 July 2017Download -
Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017
31 May 2017Download -
Formation Biologics Announces Dosing of First Patient in a Phase I/IIa Trial of AVID 100 and Closing of Series B Financing
15 May 2017Download -
Amicus SA Receives Support and Growth Capital from HBM Healthcare Investments
27 April 2017Download -
Paratek Announces Positive Phase 3 Study of Omadacycline in Community-Acquired Bacterial Pneumonia
3 April 2017Download -
Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the Treatment of Moderate to Severe Acne
27 March 2017Download